Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/ar3701 http://scihub22266oqcxt.onion/10.1186/ar3701 22364570!3392812!22364570     free     free     free       Arthritis+Res+Ther 2012 ; 14 (1): 204 Nephropedia Template TP {{tp|p=22364570|t=2012. Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus |pdf=|usr=}}{{22364570}} gab.com Text Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus JO: Arthritis Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=22364570 #FOAvip Systematic lupus erythematosus (SLE) is a complex disease for which molecular diagnostics are limited and pathogenesis is not clearly understood. Important information is provided in this regard by identification and characterization of more specific molecular and cellular targets in SLE immune cells and target tissue and markers of early-onset and effective response to treatment of SLE complications. In recent years, advances in proteomic technologies and applications have facilitated such discoveries. Here we provide a review of insights into SLE pathogenesis, diagnosis and treatment that have been provided by mass spectrometry-based proteomic approaches. Twit Text FOAVip Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus ????Arthritis Res Ther http://www.kidney.de/pget.php?&tw=1&pmid=22364570 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=22364570 #FOAvip English Wikipedia <ref>{{Cite pmid|22364570}}</ref> Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus #MMPMID22364570 Korte EA; Gaffney PM; Powell DW Arthritis Res Ther 2012[Feb]; 14 (1): 204 PMID22364570show ga Systematic lupus erythematosus (SLE) is a complex disease for which molecular diagnostics are limited and pathogenesis is not clearly understood. Important information is provided in this regard by identification and characterization of more specific molecular and cellular targets in SLE immune cells and target tissue and markers of early-onset and effective response to treatment of SLE complications. In recent years, advances in proteomic technologies and applications have facilitated such discoveries. Here we provide a review of insights into SLE pathogenesis, diagnosis and treatment that have been provided by mass spectrometry-based proteomic approaches. |Biomarkers/analysis/*metabolism[MESH] |Humans[MESH] |Lupus Erythematosus, Systemic/diagnosis/*metabolism/therapy[MESH] |Mass Spectrometry/*methods[MESH] |Proteome/analysis/metabolism[MESH] |Proteomics/*methods[MESH] |Reproducibility of Results[MESH]Contributions of mass spectrometry-based proteomics to defining cellul(epmc).pdf DeepDyve Pubget Overpricing